Development of novel targeted chemotherapeutics for the treatment ofmalignant pleural mesothelioma
Ended Project Grant Awarded Last action
- Award ID
- R44CA221543
- Recipient
-
Flag Therapeutics, Inc. UEI F1A8MRLKUP37
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,499,940
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Raleigh, NC 27617, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $712,873 | |
| Original award | $787,067 |
Quick answers
Who received award R44CA221543?
R44CA221543 was awarded to Flag Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on September 25, 2017.
How much is award R44CA221543 worth?
$1,499,940 has been obligated on R44CA221543.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award